相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Natural Cytotoxicity Receptors in Health and Disease
Alexander David Barrow et al.
FRONTIERS IN IMMUNOLOGY (2019)
Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells
Jun Arai et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Herpesvirus Evasion of Natural Killer Cells
Steffi De Pelsmaeker et al.
JOURNAL OF VIROLOGY (2018)
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Lucas Ferrari de Andrade et al.
SCIENCE (2018)
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M. Conry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
NKG2D and Its Ligands: One for All, All for One
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2018)
microRNA-889 is downregulated by histone deacetylase inhibitors and confers resistance to natural killer cytotoxicity in hepatocellular carcinoma cells
Haitao Xie et al.
CYTOTECHNOLOGY (2018)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiss et al.
CANCER RESEARCH (2018)
Implications of oxidative stress on viral pathogenesis
Fernanda Caetano Camini et al.
ARCHIVES OF VIROLOGY (2017)
Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection
Gloria Esteso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation
Shuhei Hosomi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding
Jianmin Zuo et al.
SCIENCE SIGNALING (2017)
In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells
Sayak Mukherjee et al.
SCIENCE SIGNALING (2017)
Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer
Jiaying Shen et al.
CELL DEATH & DISEASE (2017)
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation
Ceri A Fielding et al.
eLife (2017)
A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding
Jianmin Zuo et al.
SCIENCE SIGNALING (2017)
In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells
Sayak Mukherjee et al.
SCIENCE SIGNALING (2017)
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
Arthur Dyer et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2016)
Oncolytic viruses: finally delivering
Leonard W. Seymour et al.
BRITISH JOURNAL OF CANCER (2016)
The host STING pathway at the interface of cancer and immunity
Leticia Corrales et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility
Kensuke Shiraishi et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice
Marie-Louise Sentman et al.
JOURNAL OF IMMUNOLOGY (2016)
Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells
Dominik Schmiedel et al.
JOURNAL OF VIROLOGY (2016)
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression
Xiaoran Zhang et al.
NEURO-ONCOLOGY (2016)
HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillance
Yun Guan et al.
ONCOTARGET (2016)
HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion
Jonatan Enk et al.
CELL REPORTS (2016)
Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks
Antje Isernhagen et al.
FRONTIERS IN IMMUNOLOGY (2016)
Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein Expression
Ji-Hua Ren et al.
PLOS ONE (2016)
Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors
Shengjun Lu et al.
CLINICAL CANCER RESEARCH (2015)
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype
Gang Xiao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells
Alessandra Zingoni et al.
JOURNAL OF IMMUNOLOGY (2015)
Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection
Tessa M. Campbell et al.
JOURNAL OF VIROLOGY (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA*008 to Escape Elimination by NK Cells
Einat Seidel et al.
CELL REPORTS (2015)
RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Adeline R. Lam et al.
CANCER RESEARCH (2014)
Adenovirus E4ORF1-Induced MYC Activation Promotes Host Cell Anabolic Glucose Metabolism and Virus Replication
Minh Thai et al.
CELL METABOLISM (2014)
Reactive Oxygen Species- and DNA Damage Response-Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1
Alessandra Soriani et al.
JOURNAL OF IMMUNOLOGY (2014)
Altered MicroRNA Expression after Infection with Human Cytomegalovirus Leads to TIMP3 Downregulation and Increased Shedding of Metalloprotease Substrates, Including MICA
Gloria Esteso et al.
JOURNAL OF IMMUNOLOGY (2014)
A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells
Fabian Wolpert et al.
NEURO-ONCOLOGY (2014)
Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients
Courtney A. Crane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Immunological Visibility: Posttranscriptional Regulation of Human NKG2D Ligands by the EGF Receptor Pathway
Pierre Vantourout et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo et al.
ONCOTARGET (2014)
Two Novel Human Cytomegalovirus NK Cell Evasion Functions Target MICA for Lysosomal Degradation
Ceri A. Fielding et al.
PLOS PATHOGENS (2014)
The Master Regulator of the Cellular Stress Response (HSF1) Is Critical for Orthopoxvirus Infection
Claire Marie Filone et al.
PLOS PATHOGENS (2014)
The Human Adenovirus E4-ORF1 Protein Subverts Discs Large 1 to Mediate Membrane Recruitment and Dysregulation of Phosphatidylinositol 3-Kinase
Kathleen Kong et al.
PLOS PATHOGENS (2014)
The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal infected, and cancer cells
Cristina Cerbonil et al.
FRONTIERS IN IMMUNOLOGY (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells
Giulia Matusali et al.
FASEB JOURNAL (2013)
NKG2D CAR T-cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors
Paul Spear et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17
Guranda Chitadze et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
Esther M. de Kruijf et al.
BMC CANCER (2012)
Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
Anja Heinemann et al.
CANCER RESEARCH (2012)
MiR-10b Downregulates the Stress-Induced Cell Surface Molecule MICB, a Critical Ligand for Cancer Cell Recognition by Natural Killer Cells
Pinchas Tsukerman et al.
CANCER RESEARCH (2012)
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry
Heiyoun Jung et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
DNA viruses and the cellular DNA-damage response
Andrew S. Turnell et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
Julia Hilpert et al.
JOURNAL OF IMMUNOLOGY (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
Sonja Textor et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2
Hai Li et al.
CELL CYCLE (2011)
An Identical miRNA of the Human JC and BK Polyoma Viruses Targets the Stress-Induced Ligand ULBP3 to Escape Immune Elimination
Yoav Bauman et al.
CELL HOST & MICROBE (2011)
The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells
Jason M. Norman et al.
NATURE IMMUNOLOGY (2011)
Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer
Xiaohui Duan et al.
MEDICAL ONCOLOGY (2011)
Vesicular Stomatitis Virus Infection Promotes Immune Evasion by Preventing NKG2D-Ligand Surface Expression
Helle Jensen et al.
PLOS ONE (2011)
The Human Herpesvirus-7 (HHV-7) U21 Immunoevasin Subverts NK-Mediated Cytoxicity through Modulation of MICA and MICB
Christine L. Schneider et al.
PLOS PATHOGENS (2011)
Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation
Maria Tokuyama et al.
PLOS PATHOGENS (2011)
Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection
Aura Muntasell et al.
BLOOD (2010)
The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to γδ T-cell cytotoxicity
Telma Lanca et al.
BLOOD (2010)
Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
Omodele Ashiru et al.
CANCER RESEARCH (2010)
Stress-Regulated Targeting of the NKG2D Ligand Mult1 by a Membrane-Associated RING-CH Family E3 Ligase
Timothy J. Nice et al.
JOURNAL OF IMMUNOLOGY (2010)
Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2010)
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8(+) T cells glioma patients
Courtney A. Crane et al.
NEURO-ONCOLOGY (2010)
PI3K/Akt signaling mediated apoptosis blockage and viral gene expression in oral epithelial cells during herpes simplex virus infection
Mei-Ju Hsu et al.
VIRUS RESEARCH (2010)
Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
Damien Sene et al.
PLOS PATHOGENS (2010)
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
Yenan T. Bryceson et al.
BLOOD (2009)
Diverse Herpesvirus MicroRNAs Target the Stress-induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells
Daphna Nachmani et al.
CELL HOST & MICROBE (2009)
ULBP6/RAET1L is an additional human NKG2D ligand
Robert A. Eagle et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells
Nicole Schwinn et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Cutting Edge: Down-Regulation of MHC Class I-Related Chain A on Tumor Cells by IFN-gamma-Induced MicroRNA
Deepak Yadav et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
Philippe Boutet et al.
JOURNAL OF IMMUNOLOGY (2009)
NKG2D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL142
Omodele Ashiru et al.
JOURNAL OF VIROLOGY (2009)
Herpes Simplex Virus Infection Downmodulates NKG2D Ligand Expression
D. Schepis et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
HIV-1 Vpr Triggers Natural Killer Cell-Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response
Jeffrey Ward et al.
PLOS PATHOGENS (2009)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors
Cai Zhang et al.
CANCER SCIENCE (2008)
Hepatitis C Virus Infection Downregulates the Ligands of the Activating Receptor NKG2D
Chaoyang Wen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Four novel ULBP splice variants are ligands for human NKG2D
Wei Cao et al.
INTERNATIONAL IMMUNOLOGY (2008)
Intracellular retention of the NKG2D ligand MHC class I chain-related gene a in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity
Mercedes B. Fuertes et al.
JOURNAL OF IMMUNOLOGY (2008)
Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands, major histocompatibility complex class I chain-related proteins A and B
Brian P. McSharry et al.
JOURNAL OF VIROLOGY (2008)
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Qihong Huang et al.
NATURE CELL BIOLOGY (2008)
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Noam Stern-Ginossar et al.
NATURE IMMUNOLOGY (2008)
The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway
Nicholas J. Buchkovich et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn et al.
PLOS ONE (2008)
A role for NKG2D in NK cell-mediated resistance to poxvirus disease
Min Fang et al.
PLOS PATHOGENS (2008)
Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity
Mair Thomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
Arun M. Unni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Evolutionary struggles between NK cells and viruses
Lewis L. Lanier
NATURE REVIEWS IMMUNOLOGY (2008)
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Tiffany Horng et al.
NATURE IMMUNOLOGY (2007)
Promiscuity and the single receptor: NKG2D
Robert A. Eagle et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Host immune system gene targeting by a viral miRNA
Noam Stern-Ginossar et al.
SCIENCE (2007)
Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia
Severine Landais et al.
CANCER RESEARCH (2007)
In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer
Stephanie Schrambach et al.
PLOS ONE (2007)
Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D
Jessica A. Campbell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions
Matthieu Allez et al.
GASTROENTEROLOGY (2007)
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
Brett K. Kaiser et al.
NATURE (2007)
NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection
Monia Draghi et al.
JOURNAL OF IMMUNOLOGY (2007)
Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B Ligands of NKG2D
Gopalakrishnan M. Venkataraman et al.
JOURNAL OF IMMUNOLOGY (2007)
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity
Cristina Cerboni et al.
JOURNAL OF GENERAL VIROLOGY (2007)
TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells
Guenter Eisele et al.
BRAIN (2006)
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60
Tihana Lenac et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
NKG2D ligands are expressed on stressed human airway epithelial cells
Michael T. Borchers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142
NJ Chalupny et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients
NFS Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
IFN-Dependent down-regulation of the NKG2D ligand H60 on tumors
JD Bui et al.
JOURNAL OF IMMUNOLOGY (2006)
Human immunodeficiency virus type 1 Nef: Adapting to intracellular trafficking pathways
Jeremiah F. Roeth et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection
JM Routes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
NKG2D function protects the host from tumor initiation
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection
N Shirata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D Ligands by the histone deacetylase inhibitor sodium valproate
S Armeanu et al.
CANCER RESEARCH (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment
A Kudoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effect of human cytomegalovirus on expression of MHC class I-related chains A
YZ Zou et al.
JOURNAL OF IMMUNOLOGY (2005)
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145
A Krmpotic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Viral modulation of NK cell immunity
MB Lodoen et al.
NATURE REVIEWS MICROBIOLOGY (2005)
The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival
S Cooray
JOURNAL OF GENERAL VIROLOGY (2004)
Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D
L Bacon et al.
JOURNAL OF IMMUNOLOGY (2004)
The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions
MB Lodoen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma
CS Vetter et al.
BRITISH JOURNAL OF CANCER (2004)
RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
MA Friese et al.
CANCER RESEARCH (2004)
The Mre11 complex is required for ATM activation and the G2/M checkpoint
CT Carson et al.
EMBO JOURNAL (2003)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity
C Dunn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
ULBP4 is a novel ligand for human NKG2D
NJ Chalupny et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules
M Lodoen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein
J Wu et al.
JOURNAL OF IMMUNOLOGY (2003)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M Jinushi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein
SA Welte et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
Cutting edge: Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for marine NKG2D
LN Carayannopoulos et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: Inhibition of PI3-K activity inhibits viral replication and virus-induced signaling
RA Johnson et al.
JOURNAL OF VIROLOGY (2001)
Typing for all known MICA alleles by group-specific PCR and SSOP
YZ Zhang et al.
HUMAN IMMUNOLOGY (2001)
Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2)
K Yamamoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2001)
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
V Groh et al.
NATURE IMMUNOLOGY (2001)
ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
D Cosman et al.
IMMUNITY (2001)
Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta
W Wick et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
A Diefenbach et al.
NATURE IMMUNOLOGY (2000)
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
A Cerwenka et al.
IMMUNITY (2000)
分享论文
